Xiaolong Wei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Circular RNAs in diseases
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Glycosylation and Glycoproteins Research
Papers in
-
- Cancer-related gene regulation 8
- Epigenetics and DNA Methylation 7
- RNA Research and Splicing 5
- Developmental Biology and Gene Regulation 4
- Genomics and Chromatin Dynamics 4
- Oncology 18
- Cancer Cells and Metastasis 9
- Co-authors
- Guo‐Jun Zhang (23 shared papers)Donald Küfe (2 shared papers)Haiyan Xu (2 shared papers)Jing‐Wen Bai (13 shared papers)Mazhar Adli (6 shared papers)Jiekun Yang (5 shared papers)Chunfa Chen (9 shared papers)Cem Kuscu (4 shared papers)
- Journals
- PLoS ONE (4 papers)Oncotarget (3 papers)Cell Death and Disease (3 papers)Cancer Letters (3 papers)Experimental Cell Research (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaolong Wei
78 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 549
- Molecular Biology 1.4k
- Aging 34
- Business and International Management 33
- Oncology 401
Countries citing papers authored by Xiaolong Wei
This map shows the geographic impact of Xiaolong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Wei more than expected).
Fields of papers citing papers by Xiaolong Wei
This network shows the impact of papers produced by Xiaolong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Wei. The network helps show where Xiaolong Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 271 | |
| 2 | 2019 | 206 | |
| 3 | 2006 | 156 | |
| 4 | 2007 | 84 | |
| 5 | 2015 | 68 | |
| 6 | 2020 | 63 | |
| 7 | 2018 | 62 | |
| 8 | 2018 | 58 | |
| 9 | 2016 | 58 | |
| 10 | 2022 | 54 | |
| 11 | 2014 | 53 | |
| 12 | 1999 | 52 | |
| 13 | 2017 | 51 | |
| 14 | 2018 | 51 | |
| 15 | 2012 | 47 | |
| 16 | 2013 | 41 | |
| 17 | 2015 | 39 | |
| 18 | 2017 | 38 | |
| 19 | 2018 | 37 | |
| 20 | 2021 | 34 |
About Xiaolong Wei
Xiaolong Wei is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Immunology, having authored 79 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (7 papers), Breast Cancer Treatment Studies (5 papers), RNA Research and Splicing (5 papers), Developmental Biology and Gene Regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Cancer Research (549 citations), Molecular Biology (1.4k citations), Aging (34 citations), Business and International Management (33 citations) and Oncology (401 citations). Xiaolong Wei has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Guo‐Jun Zhang, Donald Küfe, Haiyan Xu, Jing‐Wen Bai, Mazhar Adli, Jiekun Yang, Chunfa Chen, Cem Kuscu, Yuanke Liang and Turan Tufan. Their work appears in journals such as PLoS ONE, Oncotarget, Cell Death and Disease, Cancer Letters and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.